Sfoglia per Autore
Correction: NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer (Breast Cancer Research (2019) 21 (133) DOI: 10.1186/s13058-019-1196-y)
2020 Jacobs, S; Robidoux, A; Abraham, J; Pérez-Garcia, J; La Verde, N; Orcutt, J; Cazzaniga, M; Piette, F; Antolín, S; Aguirre, E; Cortes, J; Llombart-Cussac, A; Di Cosimo, S; Kim, R; Feng, H; Lipchik, C; Lucas, P; Srinivasan, A; Wang, Y; Song, N; Gavin, P; Balousek, A; Paik, S; Allegra, C; Wolmark, N; Pogue-Geile, K
Neurofilament light chain serum levels as a possible paclitaxel-induced peripheral neurotoxicity biomarker: pilot and feasibility study.
2020 Alberti, P; Cicchiello, F; Riva, F; Cazzaniga, M
Genomewide Association Study of Severe Covid-19 with Respiratory Failure
2020 Ellinghaus, D; Degenhardt, F; Bujanda, L; Buti, M; Albillos, A; Invernizzi, P; Fernández, J; Prati, D; Baselli, G; Asselta, R; Grimsrud, M; Milani, C; Aziz, F; Kässens, J; May, S; Wendorff, M; Wienbrandt, L; Uellendahl-Werth, F; Zheng, T; Yi, X; de Pablo, R; Chercoles, A; Palom, A; Garcia-Fernandez, A; Rodriguez-Frias, F; Zanella, A; Bandera, A; Protti, A; Aghemo, A; Lleo, A; Biondi, A; Caballero-Garralda, A; Gori, A; Tanck, A; Carreras Nolla, A; Latiano, A; Fracanzani, A; Peschuck, A; Julià, A; Pesenti, A; Voza, A; Jiménez, D; Mateos, B; Nafria Jimenez, B; Quereda, C; Paccapelo, C; Gassner, C; Angelini, C; Cea, C; Solier, A; Pestaña, D; Muñiz-Diaz, E; Sandoval, E; Paraboschi, E; Navas, E; García Sánchez, F; Ceriotti, F; Martinelli-Boneschi, F; Peyvandi, F; Blasi, F; Téllez, L; Blanco-Grau, A; Hemmrich-Stanisak, G; Grasselli, G; Costantino, G; Cardamone, G; Foti, G; Aneli, S; Kurihara, H; Elabd, H; My, I; Galván-Femenia, I; Martín, J; Erdmann, J; Ferrusquía-Acosta, J; Garcia-Etxebarria, K; Izquierdo-Sanchez, L; Bettini, L; Sumoy, L; Terranova, L; Moreira, L; Santoro, L; Scudeller, L; Mesonero, F; Roade, L; Rühlemann, M; Schaefer, M; Carrabba, M; Riveiro-Barciela, M; Figuera Basso, M; Valsecchi, M; Hernandez-Tejero, M; Acosta-Herrera, M; D'Angiò, M; Baldini, M; Cazzaniga, M; Schulzky, M; Cecconi, M; Wittig, M; Ciccarelli, M; Rodríguez-Gandía, M; Bocciolone, M; Miozzo, M; Montano, N; Braun, N; Sacchi, N; Martínez, N; Özer, O; Palmieri, O; Faverio, P; Preatoni, P; Bonfanti, P; Omodei, P; Tentorio, P; Castro, P; Rodrigues, P; Blandino Ortiz, A; de Cid, R; Ferrer, R; Gualtierotti, R; Nieto, R; Goerg, S; Badalamenti, S; Marsal, S; Matullo, G; Pelusi, S; Juzenas, S; Aliberti, S; Monzani, V; Moreno, V; Wesse, T; Lenz, T; Pumarola, T; Rimoldi, V; Bosari, S; Albrecht, W; Peter, W; Romero-Gómez, M; D'Amato, M; Duga, S; Banales, J; Hov, J; Folseraas, T; Valenti, L; Franke, A; Karlsen, T
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence
2020 Krasniqi, E; Pizzuti, L; Barchiesi, G; Sergi, D; Carpano, S; Botti, C; Kayal, R; Sanguineti, G; Marchetti, P; Botticelli, A; Marinelli, D; Gamucci, T; Natoli, C; Grassadonia, A; Tinari, N; Tomao, S; Tonini, G; Santini, D; Michelotti, A; Mentuccia, L; Vaccaro, A; Magnolfi, E; Gelibter, A; Magri, V; Cortesi, E; D'Onofrio, L; Cassano, A; Cazzaniga, M; Moscetti, L; Fabbri, A; Scinto, A; Corsi, D; Carbognin, L; Bria, E; La Verde, N; Garufi, C; Di Stefano, P; Mirabelli, R; Veltri, E; Paris, I; Giotta, F; Lorusso, V; Landucci, E; Ficorella, C; Roselli, M; Adamo, V; Ricciardi, G; Russo, A; Valerio, M; Berardi, R; Pistelli, M; Cannita, K; Zamagni, C; Garrone, O; Baldini, E; Livi, L; Meattini, I; Del Medico, P; Generali, D; De Maria, R; Risi, E; Ciliberto, G; Villa, A; Sperduti, I; Mazzotta, M; Barba, M; Giordano, A; Vici, P
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study
2020 Bon, G; Pizzuti, L; Laquintana, V; Loria, R; Porru, M; Marchio, C; Krasniqi, E; Barba, M; Maugeri-Sacca, M; Gamucci, T; Berardi, R; Livi, L; Ficorella, C; Natoli, C; Cortesi, E; Generali, D; La Verde, N; Cassano, A; Bria, E; Moscetti, L; Michelotti, A; Adamo, V; Zamagni, C; Tonini, G; Barchiesi, G; Mazzotta, M; Marinelli, D; Tomao, S; Marchetti, P; Valerio, M; Mirabelli, R; Russo, A; Fabbri, M; D'Ostilio, N; Veltri, E; Corsi, D; Garrone, O; Paris, I; Sarobba, G; Giotta, F; Garufi, C; Cazzaniga, M; Del Medico, P; Roselli, M; Sanguineti, G; Sperduti, I; Sapino, A; De Maria, R; Leonetti, C; Di Leo, A; Ciliberto, G; Falcioni, R; Vici, P
Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: A multi-cycle, phase II study
2020 Caputo, R; Cazzaniga, M; Sbrana, A; Torrisi, R; Paris, I; Giordano, M; Montesarchio, V; Guarneri, V; Amaducci, L; Bilancia, D; Cilenti, G; Fabi, A; Collova, E; Schirone, A; Bonizzoni, E; Celio, L; De Placido, S; De Laurentiis, M
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study
2019 Cazzaniga, M; Pinotti, G; Montagna, E; Amoroso, D; Berardi, R; Butera, A; Cagossi, K; Cavanna, L; Ciccarese, M; Cinieri, S; Cretella, E; De Conciliis, E; Febbraro, A; Ferrau, F; Ferzi, A; Fiorentini, G; Fontana, A; Gambaro, A; Garrone, O; Gebbia, V; Generali, D; Gianni, L; Giovanardi, F; Grassadonia, A; Leonardi, V; Marchetti, P; Melegari, E; Musolino, A; Nicolini, M; Putzu, C; Riccardi, F; Santini, D; Saracchini, S; Sarobba, M; Schintu, M; Scognamiglio, G; Spadaro, P; Taverniti, C; Toniolo, D; Tralongo, P; Turletti, A; Valenza, R; Valerio, M; Vici, P; Clivio, L; Torri, V; Cicchiello, F; Riva, F; Vallini, I; Mazza, M; Bonfadini, C; Bordin, E; Canicatti, M; Cappuccio, F; Collova, E; De Angelis, C; Desorte, R; Donati, S; Drudi, G; Galanti, D; Mocerino, C; Orlando, L; Pellegrino, B; Pizzuti, L; Ridolfi, C; Rocca, A; Sarti, D; Spagnoletti, I; Tinari, N; Vandone, A; Vizzini, L
Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success
2019 Cazzaniga, M; Danesi, R; Girmenia, C; Invernizzi, P; Elvevi, A; Uguccioni, M; Amaducci, L; Atzori, F; Blasi, L; Butti, C; Collova, E; De Conciliis, E; Fabi, A; Febbraro, A; Garrone, O; Gianni, L; Giotta, F; La Verde, N; Michelotti, A; Palumbo, R; Paris, I; Pistelli, M; Pizzuti, L; Rubino, D; Valerio, M; Zustovich, F
Pan-European Expert Meeting on the Use of Metronomic Chemotherapy in Advanced Breast Cancer Patients: The PENELOPE Project
2019 Cazzaniga, M; Munzone, E; Bocci, G; Afonso, N; Gomez, P; Langkjer, S; Petru, E; Pivot, X; Sanchez Rovira, P; Wysocki, P; Torri, V
Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project
2019 Cazzaniga, M; Ciruelos, E; Fabi, A; Garcia-Saenz, J; Lindman, H; Mavroudis, D; Schem, C; Steger, G; Timotheadou, E; Zaman, K; Torri, V
Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future?
2019 Cazzaniga, M; Biganzoli, L; Cortesi, L; De Placido, S; Donadio, M; Fabi, A; Ferro, A; Generali, D; Lorusso, V; Milani, A; Montagna, E; Munzone, E; Orlando, L; Pizzuti, L; Simoncini, E; Zamagni, C; Pappagallo, G
Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study
2019 Cosimo, S; Verde, N; Moretti, A; Cazzaniga, M; Generali, D; Bianchi, G; Mariani, L; Torri, V; Crippa, F; Paolini, B; Scaperrotta, G; De Santis, M; Nicola, M; Apolone, G; Gulino, A; Tripodo, C; Colombo, M; Folli, S; de Braud, F
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity
2019 Cavaletti, G; Cornblath, D; Merkies, I; Postma, T; Rossi, E; Alberti, P; Bruna, J; Argyriou, A; Briani, C; Velasco, R; Kalofonos, H; Psimaras, D; Ricard, D; Pace, A; Faber, C; Lalisang, R; Brandsma, D; Koeppen, S; Kerrigan, S; Schenone, A; Grisold, W; Mazzeo, A; Padua, L; Dorsey, S; Penas-Prado, M; Valsecchi, M; Bidoli, P; Cazzaniga, M
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE
2019 Leo, S; Arnoldi, E; Repetto, L; Coccorullo, Z; Cinieri, S; Fedele, P; Cazzaniga, M; Lorusso, V; Latorre, A; Campanella, G; Ciccarese, M; Accettura, C; Pisconti, S; Rinaldi, A; Brunetti, C; Raffaele, M; Coltelli, L; Spazzapan, S; Fratino, L; Petrucelli, L; Biganzoli, L
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience
2019 Pizzuti, L; Giordano, A; Michelotti, A; Mazzotta, M; Natoli, C; Gamucci, T; De Angelis, C; Landucci, E; Diodati, L; Iezzi, L; Mentuccia, L; Fabbri, A; Barba, M; Sanguineti, G; Marchetti, P; Tomao, S; Mariani, L; Paris, I; Lorusso, V; Vallarelli, S; Cassano, A; Airoldi, F; Orlandi, A; Moscetti, L; Sergi, D; Sarobba, M; Tonini, G; Santini, D; Sini, V; Veltri, E; Vaccaro, A; Ferrari, L; De Tursi, M; Tinari, N; Grassadonia, A; Greco, F; Botticelli, A; La Verde, N; Zamagni, C; Rubino, D; Cortesi, E; Magri, V; Pomati, G; Scagnoli, S; Capomolla, E; Kayal, R; Scinto, A; Corsi, D; Cazzaniga, M; Laudadio, L; Forciniti, S; Mancini, M; Carbognin, L; Seminara, P; Barni, S; Samaritani, R; Roselli, M; Portarena, I; Russo, A; Ficorella, C; Cannita, K; Carpano, S; Pistelli, M; Berardi, R; De Maria, R; Sperduti, I; Ciliberto, G; Vici, P
NSABP FB-7: A phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer
2019 Jacobs, S; Robidoux, A; Abraham, J; Perez-Garcia, J; La Verde, N; Orcutt, J; Cazzaniga, M; Piette, F; Antolin, S; Aguirre, E; Cortes, J; Llombart-Cussac, A; Di Cosimo, S; Kim, R; Feng, H; Lipchik, C; Lucas, P; Srinivasan, A; Wang, Y; Song, N; Gavin, P; Balousek, A; Paik, S; Allegra, C; Wolmark, N; Pogue-Geile, K
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve
2018 Alberti, P; Rossi, E; Argyriou, A; Kalofonos, H; Briani, C; Cacciavillani, M; Campagnolo, M; Bruna, J; Velasco, R; Cazzaniga, M; Cortinovis, D; Valsecchi., M; Cavaletti, G
Treatment of advanced breast cancer with a metronomic schedule of oral vinorelbine: what is the opinion of Italian oncologists?
2018 Cazzaniga, M; Munzone, E; Montagna, E; Pappagallo, G
Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)
2018 Cazzaniga, M; Verusio, C; Ciccarese, M; Fumagalli, A; Sartori, D; Valerio, M; Airoldi, M; Moretti, G; Ficorella, C; Arcangeli, V; Diodati, L; Zambelli, A; Febbraro, A; Generali, D; Pistelli, M; Garrone, O; Musolino, A; Vici, P; Maur, M; Mentuccia, L; La Verde, N; Bianchi, G; Artale, S; Blasi, L; Piezzo, M; Atzori, F; Turletti, A; Benedetto, C; Cursano, M; Fabi, A; Gebbia, V; Schirone, A; Palumbo, R; Ferzi, A; Frassoldati, A; Scavelli, C; Clivio, L; Torri, V
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
2018 De Placido, S; Gallo, C; De Laurentiis, M; Bisagni, G; Arpino, G; Sarobba, M; Riccardi, F; Russo, A; Del Mastro, L; Cogoni, A; Cognetti, F; Gori, S; Foglietta, J; Frassoldati, A; Amoroso, D; Laudadio, L; Moscetti, L; Montemurro, F; Verusio, C; Bernardo, A; Lorusso, V; Gravina, A; Moretti, G; Lauria, R; Lai, A; Mocerino, C; Rizzo, S; Nuzzo, F; Carlini, P; Perrone, F; Accurso, A; Agostara, B; Aieta, M; Alabiso, O; Alicicco, M; Amadori, D; Amaducci, L; Amiconi, G; Antuzzi, G; Ardine, M; Ardizzoia, A; Aversa, C; Badalamenti, G; Barni, S; Basurto, C; Berardi, R; Bergamasco, C; Bidoli, P; Bighin, C; Biondi, E; Bisagni, G; Boni, C; Borgonovo, K; Botta, M; Bravi, S; Bruzzi, P; Buono, G; Butera, A; Caldara, A; Candeloro, G; Cappelletti, C; Cardalesi, C; Carfora, E; Cariello, A; Carrozza, F; Carteni, G; Caruso, M; Casadei, V; Casanova, C; Castori, L; Cavanna, L; Cavazzini, G; Cazzaniga, M; Chilelli, M; Chiodini, P; Chiorrini, S; Ciardiello, F; Ciccarese, M; Cinieri, S; Clerico, M; Coccaro, M; Comande, M; Corbo, C; Cortino, G; Cusenza, S; Daniele, G; D'Arco, A; D'Auria, G; Dazzi, C; De Angelis, C; de Braud, F; De Feo, G; De Matteis, A; De Tursi, M; Di Blasio, A; di Lucca, G; Di Lullo, L; Di Rella, F; Di Renzo, G; Di Stefano, P; Di Stefano, A; Diana, A; Donati, S; Fabbri, A; Fabi, A; Faedi, M; Farina, G; Farris, A; Febbraro, A; Fedele, P; Federico, P; Ferrau, F; Ferretti, G; Ferro, A; Floriani, I; Forcignano, R; Forciniti, S; Forestieri, V; Fornari, G; Frisinghelli, M; Fusco, V; Gallizzi, G; Galvano, A; Gambardella, A; Gambi, A; Gebbia, V; Gervasi, E; Ghilardi, M; Giacobino, A; Giardina, G; Giotta, F; Giraudi, S; Giuliano, M; Grassadonia, A; Grasso, D; Grosso, F; Guizzaro, L; Incoronato, P; Incorvaia, L; Iodice, G; La Verde, N; Labonia, V; Landi, G; Latorre, A; Leonardi, V; Levaggi, A; Limite, G; Lina Bascialla, L; Livi, L; Maiello, E; Mandelli, D; Marcon, I; Menon, D; Montedoro, M; Moraca, L; Moretti, A; Morritti, M; Morselli, P; Mura, A; Mura, S; Musacchio, M; Muzio, A; Natale, D; Natoli, C; Nigro, C; Nistico, C; Nuzzo, A; Orditura, M; Orlando, L; Pacilio, C; Palumbo, G; Palumbo, R; Pasini, F; Paterno, E; Pazzola, A; Pelliccioni, S; Pensabene, M; Perroni, D; Pesenti Gritti, A; Petrelli, F; Piccirillo, M; Pinotti, G; Pogliani, C; Poli, D; Prader, S; Recchia, F; Rizzi, D; Romano, C; Rossello, R; Rossini, C; Salvucci, G; Sanna, V; Santini, A; Saracchini, S; Savastano, C; Scambia, G; Schettini, F; Schiavone, P; Schirone, A; Seles, E; Signoriello, S; Signoriello, G; Silva, R; Silvestri, A; Simeon, V; Spagnoletti, I; Tamberi, S; Teragni, C; Thalmann, V; Thomas, R; Thomas, G; Tienghi, A; Tinari, N; Tinessa, V; Tomei, F; Tonini, G; Torri, V; Traficante, D; Tudini, M; Turazza, M; Vignoli, R; Vitale, M; Zacchia, A; Zagarese, P; Zanni, A; Zavallone, L; Zavettieri, M; Zoboli, A
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile